Progressive dyspnoea following the treatment of Mycobacterium abscessus infection in an individual with relapsing granulamatosis with polyangitis (Wegener’s), complicated by hearing loss requiring cochlear implantation

BMC Pulmonary Medicine

Ajay G Venkatesh¹  Senyo K Tagboto² 

[1] Cypress Regional Hospital 2004 Saskatchewan Dr. Swift Current, Saskatchewan, S9H 5M8, Canada;Consultant in Internal Medicine & Nephrology Cypress Regional Hospital 2004 Saskatchewan Dr., Swift Current, Saskatchewan, S9H 5M8, Canada

关键词: Pulmonary fibrosis;    Dyspnoea;    Mycobacterium abscessus;    Vasculitis;    Granulomatosis with polyangitis (Wegener’s);   

Others  :  1161072
DOI  :  10.1186/1471-2466-12-47

 received in 2012-01-17, accepted in 2012-08-13,  发布年份 2012

【 摘 要 】

Backgound

Granulomatosis with polyangitis (Wegener’s) is a vasculitic disease predominantly affecting the lungs, skin, kidneys, ears, nose and throat. Mycobacterium abscessus is an uncommon rapidly growing mycobacterium causing sporadic lung disease. This is the first report of both GPA and Mycobacterium abscessus pulmonary disease reported in literature.

Case Presentation

We present a case report of a 33 year old Caucasian man with relapsing disease complicated by pulmonary infection with Mycobacterium abscessus. He subsequently required bilateral cochlear implantation for progressive sensori-neural hearing loss. His M. abscessus was treated successfully with a prolonged course of antimicrobial therapy. His Granulomatosis with polyangitis (Wegener’s) relapsed towards the end of antimicrobial therapy and required treatment. Shortly after completing his antimicrobial therapy and relapse, he developed progressive dyspnea due to pulmonary fibrosis.

Conclusion

The potential causes of his progressive dyspnoea are discussed including the potential role of his underlying disease and treatment.

【 授权许可】

   
2012 Tagboto and Venkatesh; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B: Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999, 42(3):421.
• [2]Redelman-Sidi G, Sepkowitz KA: Rapidly growing mycobacteria infection in patients with cancer. Clin Infect Dis 2010, 15(4):422-434.
• [3]Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, Aviram M, Rivlin J, Picard E, Lavy A, Yahav Y, Rahav G: Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis 2008, 14(3):378-384.
• [4]Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, Adu D: Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994, 87(11):671-8.
• [5]Bacon PA: The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med. 2005, 352(4):330.
• [6]Falk RJ, Jennette JC: Rituximab in ANCA-associated disease. N Engl J Med 2010, 363(3):285.
• [7]Bhanji A, Karim M: Pulmonary fibrosis-an uncommon manifestation of anti-myeloperoxidase-positive systemic vasculitis? NDT Plus 2010, 3(4):351-353. Epub 2010 Apr 14
• [8]Tagboto S, Carr S, Varghese A, Allen A, Feehally J, Furness P: IgA nephropathy, antineutrophil cytoplasmic antibodies and cresentic glomerulonephritis in a patient with the Hermansky-Pudlak syndrome. American Journal of Nehrology 2001, 21:58-62.
• [9]Csernok E, Szymkowiak CH, Mistry N, Daha MR, Gross WL, Kekow J: Transforming growth factor-beta (TGF-beta) expression and interaction with proteinase 3 (PR3) in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Clin Exp Immunol 1996, 105(1):104-111.
• [10]Cabello-Verrugio C, Santander C, Jofre C, Acuna MJ, Melo F, Brandan E: The internal region leucine-rich repeat 6 of decorin interacts with LRP-1, modulates TGF-β dependent signaling and inhibits TGF-β dependent fibrotic response in skeletal muscles. J Biol Chem 2011. Epub ahead of print
• [11]Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990, 87:4115-4119.
• [12]Cullen AR, Cannon CL, Mark EJ, Colin AA: Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection? Am J Respir Crit Care Med. 2000, 161(2 Pt 1):641-5.
• [13]Hamada K, Nagai S, Kitaichi M, Jin G, Shigematsu M, Nagao T, Sato A, Mishima M: Cyclophosphamide-induced late-onset lung disease. Intern Med 2003, 42(1):82-7.
• [14]Hadjinicolaou AV, Nisar MK, Bhagat S, Parfrey H, Chilvers ER, Ostör AJ: Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review. Rheumatology (Oxford) 2011, 50(12):2297-305. Epub 2011 Oct 22
• [15]Davis KK, Kao PN, Jacobs SS, Ruoss SJ: Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series. BMC Pulm Med 2007, 7:2. Feb 23 BioMed Central Full Text